SCHEMBL18675838

SCHEMBL18675838

CCOC(=O)C(CCC(N)=O)OC(C)=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX15 P16050 2/20 0.39
CPB2 Q96IY4 2/20 0.36
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 3/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
HPGD P15428 1/20 0.34
CAD P27708 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GLO1 Q04760 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608496 0.87 ALOX15 (0.45) ALDH1A1LMNAHSD17B10ALOX15CPB2
SCHEMBL1268708 0.84 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10ALOX15CPB2
SCHEMBL14464925 0.81 ALOX15 (0.41) ALDH1A1LMNAHSD17B10ALOX15CPB2
SCHEMBL7399674 0.79 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10ALOX15CPB2
SCHEMBL7399669 0.79 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10ALOX15CPB2
SCHEMBL15322887 0.77 FOLH1 (0.33) TSHRTDP1
SCHEMBL6685614 0.77 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10ALOX15CYP2D6
SCHEMBL10643598 0.75 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15GLO1
SCHEMBL12150082 0.74 TDP1 (0.44) ALDH1A1LMNAHSD17B10KMT2AHPGD
SCHEMBL9439802 0.73 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10ALOX15GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088576-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2017-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088576-A1 ANTIVIRAL COMPOUNDS EIF2AK2, MAVS, ITPA ALDH1A1 4716/4885LMNA 2219/4885HSD17B10 4453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.